[What position to take for Kaposi's sarcoma in organ transplantation?]
- PMID: 1766533
[What position to take for Kaposi's sarcoma in organ transplantation?]
Abstract
Kaposi's Sarcoma (KS) is a tumor of multicentric origin, accounting for 4% of the observed neoplasia among organ transplant recipients. Its exact pathogenesis is still unknown. The diagnosis must be suspected in view of skin and/or subcutaneous tumor lesions with potential visceral involvement, which are easily confirmed by histological examination. Initial staging of the disease in 4 subgroups allows to guide therapy and prognosis. Therapeutic options depend on the transplanted organ and on results of early staging at time of diagnosis and treatment may associate: decrease and/or cessation of immunosuppression, laser therapy, radiotherapy and/or chemotherapy.
Similar articles
-
Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France.Eur J Med. 1993 Jun-Jul;2(6):339-43. Eur J Med. 1993. PMID: 8252179
-
[Kaposi's sarkoma in solid organ recipients].Przegl Lek. 2010;67(7):475-8. Przegl Lek. 2010. PMID: 21387759 Review. Polish.
-
Kaposi's sarcoma after renal transplantation in Turkey.Clin Transplant. 1998 Oct;12(5):472-5. Clin Transplant. 1998. PMID: 9787959
-
Incidence and clinical predictors of Kaposi's sarcoma among 1721 Italian solid organ transplant recipients: a multicenter study.Eur J Dermatol. 2006 Sep-Oct;16(5):553-7. Eur J Dermatol. 2006. PMID: 17101478
-
Kaposi's sarcoma.Ann Transplant. 1998;3(1):5-12. Ann Transplant. 1998. PMID: 9869891 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical